Table 1
Percentage of eyes with transient adverse events reported during the first week after treatment
Adverse event
Latanoprost
90° SLT
180° SLT
360° SLT
Discomfort/pain
0%
6%
20%
39%
Uveitis
0%
31%
41%
50%
IOP spike
0%
11%
16%
27%